Asset Details
Do you wish to reserve the book?
Disulfide-compatible phage-assisted continuous evolution in the periplasmic space
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Disulfide-compatible phage-assisted continuous evolution in the periplasmic space
Do you wish to request the book?
Disulfide-compatible phage-assisted continuous evolution in the periplasmic space
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Disulfide-compatible phage-assisted continuous evolution in the periplasmic space
2021
Overview
The directed evolution of antibodies has yielded important research tools and human therapeutics. The dependence of many antibodies on disulfide bonds for stability has limited the application of continuous evolution technologies to antibodies and other disulfide-containing proteins. Here we describe periplasmic phage-assisted continuous evolution (pPACE), a system for continuous evolution of protein-protein interactions in the disulfide-compatible environment of the
E. coli
periplasm. We first apply pPACE to rapidly evolve novel noncovalent and covalent interactions between subunits of homodimeric YibK protein and to correct a binding-defective mutant of the anti-GCN4 Ω-graft antibody. We develop an intein-mediated system to select for soluble periplasmic expression in pPACE, leading to an eight-fold increase in soluble expression of the Ω-graft antibody. Finally, we evolve disulfide-containing trastuzumab antibody variants with improved binding to a Her2-like peptide and improved soluble expression. Together, these results demonstrate that pPACE can rapidly optimize proteins containing disulfide bonds, broadening the applicability of continuous evolution.
The directed evolution of antibodies yields important tools for research and therapy. Here the authors develop a periplasmic phage-assisted continuous evolution platform for improvement of protein-protein interactions in the disulfidecompatible E. coli periplasm.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ 631/92
/ 82/1
/ Binding
/ Directed Molecular Evolution - methods
/ E coli
/ Escherichia coli - metabolism
/ Escherichia coli Proteins - genetics
/ Escherichia coli Proteins - metabolism
/ Genetic Vectors - metabolism
/ Humanities and Social Sciences
/ Methyltransferases - genetics
/ Methyltransferases - metabolism
/ Phages
/ Protein Conformation, alpha-Helical
/ Protein Conformation, beta-Strand
/ Protein Disulfide-Isomerases - genetics
/ Protein Disulfide-Isomerases - metabolism
/ Protein Interaction Domains and Motifs
/ Proteins
/ Receptor, ErbB-2 - metabolism
/ Recombinant Proteins - chemistry
/ Recombinant Proteins - genetics
/ Recombinant Proteins - metabolism
/ Science
